Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Immuneering Corporation (IMRX)

6.13 +0.24 (+4.07%)
At close: April 23 at 4:00:01 PM EDT
6.11 -0.02 (-0.32%)
After hours: April 23 at 6:36:29 PM EDT
Trade IMRX on Coinbase
Chart Range Bar
Loading chart for IMRX
Chart does not reflect overnight price.
  • Previous Close 5.89
  • Open 5.88
  • Bid 6.07 x 100
  • Ask 6.16 x 100
  • Day's Range 5.80 - 6.15
  • 52 Week Range 1.10 - 10.08
  • Volume 930,915
  • Avg. Volume 928,937
  • Market Cap (intraday) 396.594M
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) --
  • EPS (TTM) -1.27
  • Earnings Date (est.) May 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 17.00

Immuneering Corporation, a late-stage oncology company, develops medicines for broad populations of cancer patients in the United States. The company develops IMM-1-104 (atebimetinib), a dual-MEK inhibitor that is in a Phase 3 clinical trial to treat patients with cancer, including pancreatic and non-small cell lung cancer caused by mutations of RAS or RAF; IMM-6-415 (envometinib), which is in Phase 1/2a clinical trial for the treatment of patients with solid tumors; and multiple deep cyclic inhibitor discovery programs. The company has clinical supply agreements with Regeneron Pharmaceuticals to evaluate atebimetinib in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell lung cancer; and with Eli Lilly and Company to evaluate atebimetinib in combination with olomorasib in patients with advanced or metastatic KRAS G12C-mutant non-small cell lung cancer. Immuneering Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

immuneering.com

53

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News: IMRX

View More

Performance Overview: IMRX

Trailing total returns as of 4/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMRX
6.84%
S&P 500 (^GSPC)
3.84%

1-Year Return

IMRX
334.75%
S&P 500 (^GSPC)
32.23%

3-Year Return

IMRX
46.37%
S&P 500 (^GSPC)
71.97%

5-Year Return

IMRX
68.56%
S&P 500 (^GSPC)
70.05%

Earnings Trends: IMRX

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue --
Earnings -11.58M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-15M
-10M
-5M
0

Analyst Insights: IMRX

View More

Analyst Price Targets

11.00
17.00 Average
6.13 Current
30.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/9/2026
Analyst Needham
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 11 -> 11

Statistics: IMRX

View More

Valuation Measures

Annual
As of 4/22/2026
  • Market Cap

    381.07M

  • Enterprise Value

    212.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.74

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -26.07%

  • Return on Equity (ttm)

    -43.12%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -56.02M

  • Diluted EPS (ttm)

    -1.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    172.83M

  • Total Debt/Equity (mrq)

    1.75%

  • Levered Free Cash Flow (ttm)

    -28.05M

Compare To: IMRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: IMRX

Fair Value

6.13 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: IMRX

View More
  • Daily – Vickers Top Buyers & Sellers for 01/21/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/20/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/16/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Insider Picks for 11/24/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: